Bupivacaine
- Product NDC
- 57884-3252
- 11-digit product format
- 578843252
- Labeler code
- 57884
- Product ID
- 57884-3252_1c5d9dbb-0d16-6893-e063-6394a90ad989
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupivacaine
- Dosage form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INFILTRATION
- Labeler
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Application
- ANDA214348
- Marketing category
- ANDA
- Marketing start
- 2024-07-01
- Substance
- BUPIVACAINE
- Active strength
- 13.3 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupivacaine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPIVACAINE | 13.3 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | Y8335394RO |
| Rxcui | 1191508, 1745061 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 57884-3252-1 | Bupivacaine | 20 mL in 1 VIAL | INJECTION, SUSPENSION, LIPOSOMAL | 20 | | 4 |
| 57884-3252-1 | Bupivacaine | 10 in 1 CARTON | INJECTION, SUSPENSION, LIPOSOMAL | 10 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 57884-3252 | BUPIVACAINE INJECTION, SUSPENSION, LIPOSOMAL [JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.] | 4 | Current NDC, 2 package rows | 20240711_0af296bb-1599-4b35-b66b-994924d3e898.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 57884-3252-1 | 57884325201 | 10 VIAL in 1 CARTON (57884-3252-1) / 20 mL in 1 VIAL | 10 vial | 2024-07-01 | No | No | Current |